The biotechnology company is issuing $150 million of its stock as it raises funds to develop a potential cholesterol drug. Rambus Inc., down 5 cents to ...
News
- AbbVie, Lennar and FedEx fall while Bausch Health rises
- Could Syros Pharmaceuticals, Inc. (SYRS) Recover After Today's Huge Decline?
... Benzinga.com which released: “The Daily Biotech Pulse: Nabriva Stumbles At FDA Hurdle, Gilead CFO To Retire, ... Preclinical Data on SY-1365 at San Antonio Breast Cancer Symposium – Business Wire” on December 07, 2018.
- Bristol-Myers, Eldorado Resorts fall; MGM, Del Frisco's rise
AMAG Pharmaceuticals Inc., down 41 cents to $8.56. The Food and Drug Administration approved the biotechnology company's licensed drug aimed ...
- Sarissa Capital Management LP Holding in Puma Biotechnology (PBYI) Has Raised by $2.81 ...
Sarissa Capital Management Lp increased its stake in Puma Biotechnology Inc ... Logistics sued to stop merger – San Antonio Business Journal” on June 20, ... 8,825 Puma Biotechnology, Inc. (NASDAQ:PBYI) shares with value of ...
- These 3 Biotech Stocks Skyrocketed Last Week -- Are They Buys Now?
Array BioPharma was the biggest biotech winner last week, with its share ... was presented last year at the San Antonio Breast Cancer Symposium.